DA-Raf synergistically binds to the plasma membrane and Ras to suppress ERK signaling

Authors:

Abstract
The small GTPase Ras on the plasma membrane (PM) activates the ERK pathway (Raf–MEK–ERK signaling pathway) to regulate a variety of cellular, physiological, and pathological events. DA-Raf1 (DA-Raf) is a splicing isoform of A-Raf and contains the Ras-binding domain and the Cys-rich domain but lacks the conserved region 2 (CR2) and CR3 containing the kinase domain. Accordingly, DA-Raf dominant-negatively regulates Raf proteins to prevent the Ras–ERK pathway. We elucidate here the mechanisms of how DA-Raf conducts its dominant-negative function on Raf proteins. Because DA-Raf lacks the CR2 and CR3, it was incapable of adopting the autoinhibitory closed conformation and thereby favorable for PM localization. Basic amino acids in DA-Raf Ras-binding domain, and those in the Cys-rich domain, were essential for the interaction with phosphatidylserine in the PM. This interaction favored the cooperative binding of DA-Raf to active Ras, which predominated over that of Raf proteins, leading to the stable PM association of DA-Raf. Consequently, DA-Raf exerts its dominant-negative function on Raf proteins to prevent the Ras–ERK pathway.
Funding Information
  • MEXT | Japan Society for the Promotion of Science (JP17K07328, JP21K06078)
  • MEXT | Japan Society for the Promotion of Science (JP15H04348)
  • Biosignal Research Center, Kobe University (282007, 201005)
  • Kishimoto Foundation
  • Takeda Science Foundation
  • Uehara Memorial Foundation
  • Naito Foundation
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • Mitsubishi Foundation